MARKET

TIVC

TIVC

Tivic Health Systems Inc
NASDAQ
0.8581
+0.0280
+3.37%
Pre Market: 0.9394 +0.0813 +9.47% 08:10 02/09 EST
OPEN
0.8508
PREV CLOSE
0.8301
HIGH
0.8930
LOW
0.7800
VOLUME
944
TURNOVER
23.43K
52 WEEK HIGH
15.64
52 WEEK LOW
0.7800
MARKET CAP
2.17M
P/E (TTM)
-0.0869
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TIVC last week (0202-0206)?
Weekly Report · 3h ago
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 2d ago
Weekly Report: what happened at TIVC last week (0126-0130)?
Weekly Report · 02/02 09:36
PatentGrants Posts On X "Tivic Health Systems Has Received A Notice Of Allowance For A U.S. Patent Titled "MICROCURRENT MIGRAINE TREATMENT DEVICE WITH AN ADAPTIVE TRIGGER""
Benzinga · 01/28 21:00
Tivic Health, BARDA discuss entolimod for acute radiation syndrome
TipRanks · 01/28 13:35
Tivic Health Systems Presents Data On Toll-like Receptor 5 Agonist Entolimod
Benzinga · 01/28 13:33
Tivic Health Presents Entolimod Data at BARDA TechWatch Meeting
Reuters · 01/28 13:30
Tivic Health Showcases Entolimod Commercialization Strategy at DealFlow Discovery Conference
Reuters · 01/26 15:10
More
About TIVC
Tivic Health Systems, Inc. is a diversified therapeutics company, with complementary bioelectronic and biologic product candidates in its clinical pipeline. It harnesses the power of the immune and autonomic nervous systems to fight disease and restore health. It takes a multi-pronged approach to treating diseases caused by immune dysregulation and dysautonomia. The complement of bioelectronic and biologic medicines allows it to target disorders and disease via both neural pathways and molecular approaches. Its commercial product, ClearUP, is clinically proven to treat sinus pain and pressure. ClearUP is available through online retailers and commercial distributors. It also has worldwide exclusive license rights to the late-stage Toll-like Receptor 5 (TLR5) agonist Entolimod for the treatment of acute radiation syndrome (ARS). In addition, it has an exclusive option to license five additional indications and clinical use cases for Entolimod and its derivative, Entalasta.

Webull offers Tivic Health Systems Inc stock information, including NASDAQ: TIVC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TIVC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TIVC stock methods without spending real money on the virtual paper trading platform.